Corpus Intelligence IC Memo — PARKVIEW HOSPITAL 2026-04-26 06:39 UTC
IC Memo — PARKVIEW HOSPITAL
Investment Committee Memorandum | IN | 761 beds | Grade B | EBITDA uplift $122.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PARKVIEW HOSPITAL

CCN 150021 | ALLEN, IN | 761 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

PARKVIEW HOSPITAL is a 761-bed large academic medical center in ALLEN, IN with $1.66B in net patient revenue and a -6.6% operating margin. The hospital serves a payer mix of 20.1% Medicare, 3.9% Medicaid, and 76.0% commercial.

Thesis: Undervalued. Our ML models identify $122.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.6% to 0.7% (+736bps).

Net Revenue HCRIS$1.66B
Current EBITDA COMPUTED$-110.1M
Operating Margin COMPUTED-6.6%
Occupancy HCRIS73.4%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS29.1%
Distress Probability ML43.0%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
8
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -6.6% places it below the state median. Among 8 size-comparable peers (380-1522 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (380-1522), prioritizing same-state peers. 8 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PARKVIEW HOSPITAL (Target)IN761$1.66B-6.6%
INDIANA UNIVERSITY HEALTHIN1269$3.58B-38.4%
ASCENSION ST. VINCENT HOSPITALIN756$1.41B4.8%
COMMUNITY HEALTH NETWORK INC.IN387$1.24B16.4%
DEACONESS HOSPITALIN545$1.14B0.7%
FRANCISCAN HEALTH INDIANAPOLISIN401$891.4M-0.3%
MEMORIAL HOSPITAL OF SOUTH BENIN429$631.5M9.7%
COMMUNITY HOSPITALIN405$615.1M6.0%
METHODIST HOSPITALS INCIN405$390.9M-7.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $122.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$34.8M+210bp18mo
Cost to Collect4.5%2.5%$33.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$32.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$20.2M+122bp9mo
Clean Claim Rate88.0%96.0%$1.1M+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$34.8M
Cost to Collect
$33.1M
Denial Rate Reduction
$32.8M
A/R Days Reduction
$20.2M
Clean Claim Rate
$1.1M
Total EBITDA Uplift$122.0M
Current EBITDA$-110.1M
+ RCM Uplift+$122.0M
Pro Forma EBITDA$11.9M
Current Margin-6.6%
Pro Forma Margin0.7%
WC Released (1x)$63.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-169.4M$493.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-169.4M$488.3M0.00x-100.0%
Bull Case9.0x11.0x$-152.4M$835.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-152.4M$866.9M0.00x-100.0%
Bear Case11.0x10.0x$-186.3M$-61.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-186.3M$-127.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 8 hospitals with 380-1522 beds
  • Same-state prioritization (n=9)
  • Comp margins: P25=-2.1% / P50=2.8% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.